TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

4 Stocks Under $10 Making Big Moves
INVESTING

5 Breakout Stocks Ready to Surge Higher

  • By Roberto Pedone
  • May 31, 2013 2:02 PM EDT
5 Stocks Insiders Love Right Now
INVESTING

4 Hot Stocks to Trade (or Not)

  • By Jonas Elmerraji
  • May 9, 2013 1:30 PM EDT
3 Stocks Breaking Out on Unusual Volume
INVESTING

5 Big Stocks to Trade (or Not)

  • By Jonas Elmerraji
  • Mar 19, 2013 2:27 PM EDT
5 Stocks Set to Soar on Bullish Earnings
INVESTING

4 Biotech Stocks Under $5 to Watch

  • By Roberto Pedone
  • Mar 15, 2013 7:00 AM EDT
Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind
STOCKS

Biotech Stock Mailbag: Delcath, Navidea, Affymax, Ziopharm

  • By Adam Feuerstein
  • Mar 15, 2013 6:00 AM EDT
3 Stocks Breaking Out on Unusual Volume
INVESTING

5 Stocks Ready to Break Out

  • By Roberto Pedone
  • Mar 8, 2013 2:20 PM EST
5 Heavily Shorted Stocks Set to Soar on Bullish Earnings
INVESTING

5 Stocks Poised for Breakouts

  • By Roberto Pedone
  • Mar 1, 2013 2:39 PM EST
Perilous Reversal Watch: Yamana Gold (AUY)
MARKETS

3 Stocks Pushing The Drugs Industry Lower

  • By TheStreet Wire
  • Feb 25, 2013 12:05 PM EST
Sangamo's HIV Gene Therapy Is a Valuation Prop, Nothing More
STOCKS

Affymax Is Done. RIP.

  • By Adam Feuerstein
  • Feb 25, 2013 10:35 AM EST
CTI Biopharma Posts Positive Myelofibrosis Study Results
STOCKS

10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook

  • By Adam Feuerstein
  • Nov 27, 2012 6:40 AM EST
5 Stocks Insiders Love Right Now
INVESTING

3 Stocks Rising on Unusual Volume

  • By Roberto Pedone
  • Nov 9, 2012 3:47 PM EST
5 Stocks Poised for Breakouts
MARKETS

4 Health Care Stocks Rising on Big Volume

  • By Roberto Pedone
  • Oct 22, 2012 2:36 PM EDT
Inflating Market Bubble Not Quite Ready to Pop
MARKETS

4 Stocks Moving Higher With Volume

  • By Roberto Pedone
  • Oct 10, 2012 1:48 PM EDT
Jim Cramer's 'Mad Money' Recap: Fear and Loathing on Wall Street
JIM CRAMER

Cramer's 'Mad Money' Recap: When Progress Isn't Good

  • By Scott Rutt
  • Sep 18, 2012 8:11 PM EDT
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Nektar Therapeutics Is a Short

  • By Martin Shkreli
  • Sep 12, 2012 7:08 AM EDT
Earnings Preview: Dow Stocks J&J, Travelers and Verizon Report Premarket Tuesday
MARKETS

4 Big-Volume Stocks Surging Higher

  • By Roberto Pedone
  • Aug 20, 2012 1:50 PM EDT
Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
STOCKS

Biotech Stock Mailbag: Amarin or Arena Takeout?

  • By Adam Feuerstein
  • Jul 6, 2012 6:00 AM EDT
Hedge Funds Love These 5 Consumer Stocks -- but Should You?
INVESTING

8 Stocks Rising on Monster Volume

  • By Roberto Pedone
  • Apr 2, 2012 1:01 PM EDT
MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales
STOCKS

Biotech Stock Mailbag: MAP Pharma, Affymax

  • By Adam Feuerstein
  • Mar 30, 2012 5:30 AM EDT
5 Hated Earnings Stocks You Should Love
INVESTING

8 Stocks Rising on Huge Volume

  • By Roberto Pedone
  • Mar 23, 2012 2:08 PM EDT
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Biotech Stock Mailbag: Xoma's Big Backers, FDA Approvals Contest

  • By Adam Feuerstein
  • Mar 23, 2012 5:30 AM EDT
The Next Big Thing in Biotech: FDA Decisions
VIDEO

The Next Big Thing in Biotech: FDA Decisions

  • By Gregg Greenberg
  • Mar 23, 2012 5:00 AM EDT
Vertex Pharma Cystic Fibrosis FDA Advisory Panel Live Blog
INVESTING

Biotech Stock Chat: Recap

  • By Adam Feuerstein
  • Mar 15, 2012 11:54 AM EDT
4 Under-$10 Biotech Stocks in Breakout Territory
INVESTING

5 Stocks Ready to Soar on Bullish Earnings

  • By Roberto Pedone
  • Mar 13, 2012 6:12 AM EDT
Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
STOCKS

More Biotech Twitter Mailbag: Orexigen, Affymax, YM Bio, Spectrum & More

  • By Adam Feuerstein
  • Feb 29, 2012 7:03 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.